Your browser doesn't support javascript.
loading
Clonal variation in interferon response determines the outcome of oncolytic virotherapy in mouse CT26 colon carcinoma model.
Ruotsalainen, J J; Kaikkonen, M U; Niittykoski, M; Martikainen, M W; Lemay, C G; Cox, J; De Silva, N S; Kus, A; Falls, T J; Diallo, J-S; Le Boeuf, F; Bell, J C; Ylä-Herttuala, S; Hinkkanen, A E; Vähä-Koskela, M J.
Afiliação
  • Ruotsalainen JJ; A.I. Virtanen Institute for Molecular Sciences, Department of Biotechnology and Molecular Medicine, University of Eastern Finland, Kuopio, Finland.
  • Kaikkonen MU; A.I. Virtanen Institute for Molecular Sciences, Department of Biotechnology and Molecular Medicine, University of Eastern Finland, Kuopio, Finland.
  • Niittykoski M; A.I. Virtanen Institute for Molecular Sciences, Department of Biotechnology and Molecular Medicine, University of Eastern Finland, Kuopio, Finland.
  • Martikainen MW; A.I. Virtanen Institute for Molecular Sciences, Department of Biotechnology and Molecular Medicine, University of Eastern Finland, Kuopio, Finland.
  • Lemay CG; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Canada.
  • Cox J; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Canada.
  • De Silva NS; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Canada.
  • Kus A; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Canada.
  • Falls TJ; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Canada.
  • Diallo JS; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Canada.
  • Le Boeuf F; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Canada.
  • Bell JC; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Canada.
  • Ylä-Herttuala S; A.I. Virtanen Institute for Molecular Sciences, Department of Biotechnology and Molecular Medicine, University of Eastern Finland, Kuopio, Finland.
  • Hinkkanen AE; A.I. Virtanen Institute for Molecular Sciences, Department of Biotechnology and Molecular Medicine, University of Eastern Finland, Kuopio, Finland.
  • Vähä-Koskela MJ; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Canada.
Gene Ther ; 22(1): 65-75, 2015 Jan.
Article em En | MEDLINE | ID: mdl-25231172
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus da Floresta de Semliki / Neoplasias do Colo / Vírus Oncolíticos / Terapia Viral Oncolítica Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus da Floresta de Semliki / Neoplasias do Colo / Vírus Oncolíticos / Terapia Viral Oncolítica Idioma: En Ano de publicação: 2015 Tipo de documento: Article